Safadi-Chamberlain Farida, Wang Li-Ping, Payne Shawn G, Lim Chang-Uk, Stratford Suzanne, Chavez Jose Antonio, Fox Michael H, Spiegel Sarah, Summers Scott A
Department of Biochemistry and Molecular Biology, Colorado State University, Fort Collins, CO 80523-1870, USA.
Biochem J. 2005 Jun 15;388(Pt 3):827-34. doi: 10.1042/BJ20041726.
Numerous extracellular stimuli activate SK1 (sphingosine kinase type 1) to catalyse the production of sphingosine 1-phosphate, a bioactive lipid that functions as both an extracellular ligand for a family of G-protein-linked receptors and as a putative intracellular messenger. Phorbol esters, calcium or immunoglobulin receptors stimulate SK1 by promoting its translocation to the plasma membrane, which brings it into proximity both to its substrate (i.e. sphingosine) and to activating acidic phospholipids (e.g. phosphatidylserine). To evaluate the consequence of SK translocation, we generated an SK1-derivative tagged with a myristoylation sequence (Myr-SK1) on its N-terminus and overexpressed the construct in 3T3-L1 fibroblasts using recombinant retrovirus. Myr-SK1 overexpression increased SK activity by more than 50-fold in crude membranes, while only stimulating cytoplasmic SK activity by 4-fold. In contrast, the overexpression of WT-SK1 (wild-type SK1), as well as that of a construct containing a false myristoylation sequence (A2-Myr-SK1), markedly increased SK activity in both membrane and cytoplasmic compartments. Immunofluorescence confirmed that Myr-SK1 preferentially localized at the plasma membrane, whereas WT-SK1 and A2-Myr-SK1 partitioned in cytoplasmic/perinuclear cellular regions. Surprisingly, Myr-SK1 overexpression significantly decreased the rates of cell proliferation by delaying exit from G0/G1 phase. Moreover, expression of Myr-SK1 but not WT-SK1 or A2-Myr-SK1 protected cells from apoptosis induced by serum withdrawal. Collectively, these findings reveal that altering the subcellular location of SK1 has marked effects on cell function, with plasma membrane-associated SK having a potent inhibitory effect on the G1-S phase transition.
众多细胞外刺激可激活1型鞘氨醇激酶(SK1),以催化生成1-磷酸鞘氨醇,这是一种生物活性脂质,它既作为一类G蛋白偶联受体的细胞外配体,又作为一种假定的细胞内信使发挥作用。佛波酯、钙或免疫球蛋白受体通过促进SK1转位至质膜来刺激SK1,这使其与底物(即鞘氨醇)以及激活酸性磷脂(如磷脂酰丝氨酸)接近。为了评估SK转位的后果,我们构建了一种在其N端带有肉豆蔻酰化序列(Myr-SK1)的SK1衍生物,并使用重组逆转录病毒在3T3-L1成纤维细胞中过表达该构建体。Myr-SK1的过表达使粗制膜中的SK活性增加了50多倍,而仅使细胞质中的SK活性增加了4倍。相比之下,野生型SK1(WT-SK1)以及含有假肉豆蔻酰化序列的构建体(A2-Myr-SK1)的过表达,显著增加了膜和细胞质区室中的SK活性。免疫荧光证实,Myr-SK1优先定位于质膜,而WT-SK1和A2-Myr-SK1则分布在细胞质/核周细胞区域。令人惊讶的是,Myr-SK1的过表达通过延迟从G0/G1期退出而显著降低了细胞增殖速率。此外,Myr-SK1而非WT-SK1或A2-Myr-SK1的表达可保护细胞免受血清剥夺诱导的凋亡。总的来说,这些发现表明,改变SK1的亚细胞定位对细胞功能有显著影响,与质膜相关的SK对G1-S期转变具有强大的抑制作用。